Xponance’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.3K | Sell |
19,940
-787
| -4% | -$1.35K | ﹤0.01% | 1476 |
|
|
2025
Q1 | $69K | Buy |
20,727
+1,120
| +6% | +$3.73K | ﹤0.01% | 1377 |
|
|
2024
Q4 | $145K | Buy |
19,607
+3,066
| +19% | +$22.7K | ﹤0.01% | 1326 |
|
|
2024
Q3 | $155K | Buy |
16,541
+262
| +2% | +$2.46K | ﹤0.01% | 1275 |
|
|
2024
Q2 | $131K | Buy |
16,279
+1,873
| +13% | +$15K | ﹤0.01% | 1226 |
|
|
2024
Q1 | $213K | Buy |
14,406
+557
| +4% | +$8.26K | ﹤0.01% | 1170 |
|
|
2023
Q4 | $113K | Buy |
13,849
+390
| +3% | +$3.17K | ﹤0.01% | 1203 |
|
|
2023
Q3 | $61.2K | Buy |
13,459
+1,215
| +10% | +$5.53K | ﹤0.01% | 1192 |
|
|
2023
Q2 | $86.2K | Buy |
+12,244
| New | +$86.2K | ﹤0.01% | 1202 |
|
|
2021
Q2 | – | Sell |
-14,531
| Closed | -$460K | – | 1256 |
|
|
2021
Q1 | $460K | Buy |
14,531
+195
| +1% | +$6.17K | 0.01% | 814 |
|
|
2020
Q4 | $665K | Sell |
14,336
-61
| -0.4% | -$2.83K | 0.01% | 620 |
|
|
2020
Q3 | $474K | Buy |
14,397
+72
| +0.5% | +$2.37K | 0.01% | 666 |
|
|
2020
Q2 | $393K | Buy |
+14,325
| New | +$393K | 0.01% | 717 |
|